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Abstract 
Objective. To describe and compare the decisions critical for survival or quality of life (CDs) made for patients with 
advanced dementia in nursing homes (NHs) and home care (HC) services. 
Design. Prospective cohort study with a follow-up of 6 months. 
Setting. Lombardy Region (NHs) and Reggio-Emilia and Modena Districts (HC), Italy. 
Participants. Patients (496 total; 315 in NHs and 181 in HC) with advanced dementia (Functional Assessment Staging 
Tool score >7) and expected survival >2 weeks. 
Measurements. At baseline, the patients’ demographic data, date of admission and of dementia diagnosis, type of 
dementia, main co-morbidities, presence of pressure sores, ongoing treatments, and current prescriptions were 
abstracted from clinical records. At baseline and every 15 days thereafter, information regarding the patients’ general 
condition and CDs (deemed critical by the doctor or team) was collected via interview with the doctor. For each CD, the 
physician reported the problem that led to the decision, the decision that was eventually made, the purpose of the 
decision, whether the decision had been discussed with and/or communicated to the family, who made the final 
decision, whether the decision was maintained after one week, whether it corresponded to what the doctor would have 
judged appropriate, and the expected survival of the patient (≤15 days).  
Results. For 267 of the 496 patients (53.8%; 60.3% in NHs and 42.5% at home), 644 CDs were made; for 95 patients, 
more than one CD was made. The problems that led to a CD were mainly infections (respiratory tract and other 
infections; 46.6%, 300/644 CDs); nutritional/hydration problems (20.6%; 133 CDs) and the worsening of a pre-existing 
disease (9.3%; 60 CDs). The most frequent type of decision concerned the prescription of antibiotics (overall 41.1%, 
265/644; among NH patients 44.6%, 218/488; among HC patients, 30.2%, 47/156). The decision to hospitalize the 
patient was more frequently reported for HC than NH patients (25.5% vs. 3.1%). The most frequent purposes of the 
CDs in both settings were reducing symptoms or suffering (more so in NHs; 81.1 vs. 57.0% in HC) and prolonging 
survival (NH 27.5%; HC 23.1%; multiple purposes were possible). For 26 decisions (3.8%), the purpose was to ease 
death or not to prolong life. 
Conclusions. Decisions critical for the survival or quality of life of patients with advanced dementia were made for 
approximately half of the patients during a 6-month time frame, and such decisions were made more frequently in NHs 
than in HC. HC patients were more frequently hospitalized, and a sizeable minority of these patients were treated with 
the goal of prolonging survival. Italian patients with advanced dementia may benefit from the implementation of 
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palliative care principles, and HC patients may benefit from the implementation of measures to avoid hospitalizing 
patients near the end of life. 
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Introduction  
 Physicians who care for older people near the end of life frequently make difficult decisions that balance 
medical, ethical, psychosocial, and societal considerations. Such critical decisions (CDs) may affect the time of death 
(hastening or postponing it), the place of death (home, hospital or nursing homes [NHs]),1 and/or the manner in which 
the person will live his/her last days.2 These decisions may involve admitting a patient to a hospital or a NH or 
withholding or withdrawing a treatment. In the case of advanced dementia, these decisions are complicated by the 
patient’s incapacity and often by a lack of clear preferences. In the absence of a surrogate and of advanced directives 
(ADs), regardless of whether the family is involved in decisions, the ultimate responsibility for prescribing treatment 
falls on the physician: the physician is the prescriber, and must act in accordance with her/his professional and ethical 
standards.3 Advanced dementia may be perceived as a terminal condition,4,5  but because patients can survive for years 
with this condition, they are often exposed to aggressive and/or inappropriate treatments.6 
 Decisions to forgo artificial nutrition and hydration are among the most difficult and controversial ones7,8, but even 
routine clinical decisions can impact the patients’ quality of life and/or survival. Examples of such decisions are 
whether to use restraints for patients who oppose treatments, to sedate an agitated patient, or to prescribe invasive 
diagnostic tests. The literature highlights important differences among countries,9 and it is likely that differences exist 
among institutions and settings within the same country.10 Few studies have described the range of CDs for this 
population, and most focused on specific decisions.11,12 
 Little is known about the purposes of this kind of decisions for patients with advanced dementia. However, some 
papers13-17analyzed end-of-life decisions in different countries retrospectively interviewing the physicians who had 
cared for the deceased person. An exploratory retrospective study18 suggested that in Italy, clinical decisions in NHs 
during the last months of life were mostly curative, and palliative care had only a marginal role. To date, no studies 
have presented all of the decisions perceived as critical by the doctors who care for patients with advanced dementia.  
 The primary goal of this study is to describe and compare the CDs made for patients with advanced dementia in 
NHs and in home care services (HC). Descriptions of such decisions may deepen our insight into the care that patients 
with advanced dementia receive, highlight problems faced by health care professionals in NHs and HC, and suggest 
areas where decision-making support is needed. 
Methods 
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 A multicenter prospective observational cohort study (the End-Of-Life Observatory: Prospective Study on 
DEmentia patients Care [EOLO-PSODEC] study) was conducted from June 2007 to May 2009.19 The aims were to 
describe the treatments, discomfort, and CDs made for patients with advanced-stage dementia. 
Setting and sample   
 A CD is the decision to start, withdraw, or withhold a treatment that the physician and/or the health care team 
perceive as critical to a patient’s survival and/or quality of life. The following are examples of such decisions: 
-Starting a treatment: the decision to start a new treatment or to restart a treatment that was stopped previously; 
-Withholding a treatment: the decision to abstain from intervening in clinical situations that might have required action 
according to disease-specific guidelines or as a default: e.g., deciding not to perform diagnostic tests when prostate 
cancer is suspected; not starting tube feeding in a dysphagic patient; or not transfusing a patient despite severe anemia; 
-Withdrawing a treatment: the decision to stop a therapy/treatment once it has begun. 
     Because of regional regulations, the organizational model of care (NHs vs. HC) in Italy implies important 
differences in the services provided to patients with dementia. This study was conducted in two regions: Lombardy, 
where care for patients with advanced dementia is mainly provided in certified NHs, and Emilia-Romagna, where 
service is mainly based on HC. In 2007, in Lombardy were 631 NHs, ranging in size from 19 to 700 beds (54,000 beds 
total).20 In these NHs, a doctor is always available: either on site in larger facilities or on call in smaller facilities.  These 
NHs have their own staff of physicians, nurses, physiotherapists, psychologists, and health aides. Several NHs doctors 
are specialized in Geriatrics or Internal Medicine. The residents are older people with major disabilities and post-acute 
patients who need long-term rehabilitation. Some NHs have specialized dementia wards. The NHs differ widely in the 
numbers of inpatients and services offered (i.e., occupational therapy, day care for Alzheimer’s disease patients, 
cognitive therapy, physiotherapy, music therapy, etc.). Very few NHs offer palliative care consultation.  
     In Emilia Romagna, multidisciplinary teams provide disabled older people with assistance at home. HC consists of 
visiting nurses, who refer for the medical aspects of care to the patient’s general practitioner (GP). Only a few GPs have 
specialized in Geriatrics.  HC may also include visits by psycho-geriatricians, palliative-care consultants, social 
workers, and volunteers. Patients are given HC services only if they have a specific problem that requires nursing care, 
such as an indwelling catheter, a feeding tube, or a pressure sore. Patients are transferred to a NH only if their family 
caregiver is unable to provide sufficient care at home. 
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 All 14 NHs with >300 beds were recruited to participate in this study, and a random sample of smaller NHs of the 
Lombardy Region (8% of the total), stratified into 8 strata based on the number of beds, as were the 5 districts (2 urban 
and 3 rural) of the Reggio-Emilia and Modena Provinces of the Emilia-Romagna Region. Only one of the NHs that was 
contacted refused to participate. Patients with a Functional Assessment Staging Tool (FAST)21 score ≥7 were enrolled. 
The FAST, a test designed to assess Alzheimer’s disease, measures 7 main stages of dementia. Stage7, the most 
advanced stage, is divided into 6 progressive sub-stages: 7a, speech limited to 1-5 words; 7b, loss of all intelligible 
vocabulary; 7c, no walking; 7d, unable to sit independently; 7e, unable to smile; 7f, unable to hold head up. Only 
patients with an expected survival ≥2 weeks at baseline according to their primary doctor’s clinical judgment were 
enrolled.  
Data collection 
 Trained nurses employed by the NHs or the districts collected the data. Where the number of eligible patients 
exceeded the staff’s capacity to collect all data, the coordinating center selected an appropriate sample of patients using 
a random number table. At baseline, on a given day, the researchers abstracted information from the clinical records 
that included demographic data, the date of admission and of the dementia diagnosis, the type of dementia, the main co-
morbidities, ongoing treatments (artificial nutrition and hydration, dialysis, rehabilitation, mechanical ventilation, 
oxygen, restraints), and any current prescriptions (type of medication; dosages and indications were not collected). 
Pressure sores were documented only if they were > stage II (National Pressure Ulcer Advisory Panel [NPUAP] II;22 
disepithelization). Discomfort was assessed every 2 weeks until death or the end of the follow-up (6 months) using the 
validated Italian translation23 of the Discomfort Scale-Dementia of Alzheimer Type (DS-DAT).24 At the same time, data 
were collected about the patients’ general condition; any changes in the treatment plan, along with the reasons for the 
change; DS-DAT scores; and CDs.  
    Physicians were interviewed to identify CDs, and patients’ medical records were examined to collect data on 
significant health problems -for example pneumonia or severe dehydration. We asked if problems possibly involved a 
CD. Thus, the additional examination of clinical records was used to minimize the chance of missing a CD. When two 
or more decisions were reported together during the same follow-up period for the same patient, the research panel 
selected the main intervention: for instance, “hydration and diagnostic exams” was classified as “hydration”. 
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 The problem that led to the each CD was selected from a predefined list based on previous research on CDs among 
Italian NH doctors,18 and an open-ended option was available to add information about any other decision that was 
perceived as critical. The doctor who made the decision was interviewed regarding the purpose of that decision; 
whether the decision had been discussed beforehand with, and/or communicated to, the family or to the patient’s legal 
representative; who made the final decision; the expected survival of the patient (≤15 days) at the time the decision was 
made; whether the decision was maintained after one week; and whether it corresponded to what the doctor would have 
deemed appropriate. Any refusal to participate in the interview was recorded. Information about the interviewed doctors 
was also collected.   
Statistical analyses 
 The data are shown as absolute and/or relative frequencies for categorical data and as the mean ± SD or median and 
interquartile range (IQR) for continuous variables. The Shapiro-Wilk normality test was used to check the normality of 
continuous variables. The chi-square test was used for categorical variables. For continuous variables, t-tests for 
independent data or Mann-Whitney tests for non-normally distributed data were used to assess possible differences 
between the two groups. For all tests, the significance level was set at 0.05. All analyses were performed with Stata 12. 
Results 
 A cohort of 496 patients (315 in the NHs and 181 in HC) was recruited (Table 1). Overall, one-third of the patients 
(34.2%) had Alzheimer-type dementia (40.0% in the NHs and 22.1% in HC). The patients receiving HC were older, 
more frequently male, and in more advanced stages of dementia, although they had fewer comorbid diseases. Almost all 
of the patients had at least one comorbid or concurrent condition (NHs 302/315, range 0-8, median 3; HC 172/181, 
range 0-10, median 2). At baseline, some of the NH patients received hydration (14.6%) or tube feeding (8.6%); the 
percentages were similar for the HC patients.  
 For 98 patients (20.6%; 21 patients were missing these data), the survival time at the specified follow-up period was 
estimated as ≤15 days. Only 3 NH patients had an advanced directive. In the NHs, most patients (248; 80.5%) received 
weekly visits from a relative; 40 (13.9%) received visitors monthly, and 20 (6.5%) received visitors less frequently. All 
except 6 of the NH patients (301, 95.5%) had an informal caregiver (a relative). 
Follow-up 
 Three hundred sixty-two patients (72.9%) were followed up to 6 months: 73.2% (230) in the NHs and 73.3% (132) 
in HC. The reasons for not having further follow up (134; 27.1%) were death (20.2%; 100 overall, same percentages in 
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NHs and HC) and for 5 patients in each group, permanent (until death) admission to another institution or to the 
hospital without return to the NH or HC. In a few cases (24; 4.8%), the reason was not recorded. 
Critical decisions and underlying problems 
 During the 6 months in 12.9% of the follow-ups (644/4988), CDs were made for 267 patients (95 had two or more 
CDs): 190 patients in NHs (60.3%) and 77 in HC (42.5%), with a range of 1-11 CDs (median 3) among the NH patients 
and 1-5 (median 2) among the HC patients. No CDs were made for 46% of patients (229/496). The proportion of 
patients without CDs was higher in HC (HC: 104, 57.5%; NHs: 125, 39.7%; p<0.001). All interventions were withheld 
in 5.6% of the CDs (36/644). The problems that led to a CD (Table 2) were mainly infections (respiratory tract and 
other infections; 46.5%, 300/644 CDs) and nutritional problems (20.6%, 133 CDs), and, less frequently, the worsening 
of a pre-existing disease (9.3%, 60 CDs). 
Typology of critical decisions 
 The CDs in the NHs and in HC are reported in Table 3; the most frequent was to administer antibiotics (26.6% in 
the NHs and 25.7% in HC); antibiotics plus hydration were provided more frequently in the NHs than in HC (18.0% vs. 
4.5%). The decision to hospitalize a patient was more frequently reported in HC (25.5%) than in the NHs (3.1%). The 
reasons for hospitalization also differed: in HC, of the 39 hospitalizations, 6 were for acute events (falls, seizures, and 
other reasons), and all of the other were for the worsening of general conditions, infections and dysphagia. In contrast, 
in the NHs, the majority of the 15 hospitalizations were associated with acute/severe events (falls, 5 cases; anemia, 4 
cases). Overall, for 61 patients (15.2% in the NHs and 7.1% in HC), the prognosis had worsened at follow-up, and these 
patients were expected to live ≤15 days. However, no NH patients with a prognosis of ≤15 days were admitted to the 
hospital; only 2 HC patients (of 42 admissions), one with a prognosis of ≤15 days, were admitted to the hospital. 
Furthermore, 3 HC patients were admitted to a NH (not shown). 
 In HC, the withholding of all possible interventions was also more frequent (11.5% vs. 3.7% in NHs), although in 
the NHs this withholding was most often applied to patients with a ≤15 day prognosis (10/18 vs. 4/18). The 29 CDs 
regarding the administration of drugs (other than antibiotics) mainly referred to steroids (16 cases) and morphine (11 
cases). Other drugs were dopamine, nitrates, and laxatives (the number exceeds 29 because the decision involved 
administering more than one drug to the same patient in 3 cases).  
Roles in the decision-making process  
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 Physicians autonomously took over half of the decisions (57.7%, 345/598; missing information, 46); in 88 cases 
(14.7%), decisions were made together with the family. In only 3 cases (0.5%), the final decisions were made by the 
family or by the patient’s legal representative; all of these decisions concerned withholding interventions. In HC, all but 
4 decisions were discussed with the family (96.5%, 111/115; 41 patients were missing this information). In the NHs, 
only half of the CDs (50.0%; 11 cases were missing information) were discussed before they were implemented: in the 
other cases, they were mostly (76.0%) communicated to the family post hoc. In HC, all decisions to withhold all 
interventions were made with the family, were maintained and, with the exception of two cases, corresponded with 
what the physician would have preferred. 
Purpose of the decisions 
 For 456/644 CDs (70.8%), a single purpose was reported; for 135 (21.0%), two purposes were reported; and for 11 
CDs (1.7%), three or four purposes were reported (Table 4). There were significant differences in the distributions of 
the purposes of the decisions between the NHs and HC (p=0.001 selecting decisions with single purposes). In both 
settings, reducing symptoms or suffering (NH 81.1%; HC 57.0%) and prolonging survival (NH 27.5%; HC 23.1%) 
were the most frequent purposes of the CDs (additional purposes were possible). Prolonging survival was the single 
purpose for 63.8% (23/36) of the decisions in HC and 33.5% (45/134) in the NHs. In the other 102 cases, the purposes 
were prolonging life associated to reducing symptoms and suffering. 
 In 31 cases, the purpose was to “ease death” (i.e., improve the quality of death by minimizing suffering as death 
approaches, in accordance with the philosophy of palliative care; the physicians surveyed were all made aware of this 
definition) or “not to prolong life” (in 3 cases, both purposes were stated for the same decision). In 18 of these cases, 
the prognosis was ≤15 days. “Easing death” was never the only purpose of a decision.  
 A minority of the CDs about whether to administer antibiotics associated with parenteral hydration (9.4%, 25/265) 
cited prolonging survival as their single goal (11.5%, 25/218 in the NHs and none in HC); these decisions included 13 
patients with an estimated survival of ≤15 days. In the majority of the cases (64.1%, 170/265 CDs), “reducing 
symptoms/suffering” was the sole purpose of the decision (61.5%, 134/218 in NHs and 76.6%, 36/47 in HC). Less 
frequently (22.6%, 60/265), the two goals were combined (24.8%, 54/218 in NHs and 12.8%, 6/47 in HC). Other goals 
or combinations were not frequent.  
 The 11 NH decisions to start artificial nutrition were aimed at prolonging survival in 8 cases and at reducing 
symptoms and suffering in 6 cases (in 3 cases, both purposes were reported). Tube feeding was started in one NH 
patient who was expected to die within 15 days. “To avoid prolonging life” was the single or a concurrent purpose cited 
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in 7 decisions. Five hundred thirteen CDs (85.8%; information missing for 46) were maintained after one week; 
577/591 CDs (97.6%) corresponded with what the doctor would have chosen for the patient (information missing for 
53). We did not collect information on physicians’ academic qualifications. The large majority of decisions (396/488 in 
NHs and 131/156 in HC) were made by doctors with >5 years of experience (NHs: 47 decisions were made by doctors 
with 1-5 years of experience; HC: 23 decisions were made by doctors with 1-5 years of experience). 
Discussion  
 To our knowledge, this is the first study to prospectively describe CDs for patients with advanced dementia from the 
health care professionals’ perspective. Other studies have reported only on specific decisions.1, 10-12, 25 We found that 
CDs were made for roughly half of the patients with advanced dementia within a 6-month time window, and such 
decisions occurred more frequently in NHs (60.3%) than in HC (42.5%). 
      When a caregiver is available and the situation (e.g., home facilities and/or availability of services) allows, relatives 
prefer to keep the patient at home until the end.26 Patients are usually admitted to HC services only if they have specific 
problems that require nursing care, and to NHs if the family caregiver is not able to manage the patient at home.27 This 
may explain the higher baseline prevalence of pressure sores in HC patients and some other differences that do not 
necessarily indicate poorer care in HC than in NHs. During the six-month observation period, no CDs were made for 
229 patients (46.1%). This result illustrates a highly uncertain trajectory: patients with advanced dementia may also 
remain in stable conditions for long periods.28 
 The problems that most frequently led to a CD were infections, especially of the respiratory system; nutritional 
problems; and problems related to the worsening of clinical conditions. However, the choice of treatment for controlling 
symptoms such as restlessness can also be perceived as a CD. Even the decision to administer opioids, a decision that 
most clinicians would consider to represent mere standard care, was considered a CD in 11 cases. The under-
prescription of analgesics has been described previously,19  using data collected for the present study. In Italy, despite 
improvements that have occurred in recent years, prescribers continue to exhibit a strong bias towards the (alleged) side 
effects of opioids,29 and training programs are needed to change this attitude. Because of these biases, in some 
circumstances, drugs other than opioids such as antibiotics may have been prescribed to reduce symptoms of infection 
instead of analgesics, with questionable effectiveness.   
 Because the appropriateness of some prescriptions is questionable in comparable populations19 and no widely 
accepted guidelines are available, a thorough risk/benefit evaluation is sometimes difficult to perform. The types of 
problems that led to a CD differed between NHs and HC. In the NHs, more CDs for respiratory tract infections and 
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fewer for other infections may reflect either a greater incidence of respiratory infections in NHs, a different perception 
of the “criticality” of decisions concerning respiratory infections in HC, or both. 
 The most frequently made CD was the decision to administer antibiotics. Antibiotics may be used to treat 
pneumonia or to relieve symptoms. An observational study showed a lower 10-day mortality rate in patients with 
advanced dementia and pneumonia who were treated with antibiotics (HR 0.51- 95%; CI 0.30 - 0.87) compared with 
those who were not treated;30 however, there was no reduction in long-term mortality. This finding suggests that in 
many cases antibiotics prolong dying rather than prolonging survival. Antibiotics can also be used to improve 
comfort31,32 by reducing symptoms such as bronchial congestion and dyspnea. In one-tenth of the cases in our study, 
antibiotics were used only to prolong survival, primarily by treating an infection. In the large majority of the cases, the 
sole purpose (66%) of administering antibiotics was to reduce symptoms and suffering; in less than one-fourth of the 
cases, antibiotics were used to prolong survival associated to reduce symptoms and suffering. 
 Clinical decisions about prescribing or withholding antibiotics seem to be difficult, and prognosis may play a role in 
decision making.33 The goal of prolonging life is considered inconsistent with the palliative philosophy, and it is even 
less appropriate in cases of advanced dementia.7 Nonetheless, these findings confirm the existence of a gap between the 
recommendations of palliative care philosophy and the positions of doctors34 and nurses,35 who seem, at least in Italy, 
culturally more inclined to prolong life and thus to favor the administration of antibiotics.  
 While few of the CDs in this study related to artificial nutrition (2.3%, and only in the NHs), a substantial minority 
of the patients had feeding tubes at baseline (almost 10%). CDs regarding artificial hydration were more common and 
occurred very frequently in the NHs (39.8% vs. 16.0% in HC); at baseline, as many as 15.4% of HC and 14.6% of NH 
patients were already artificially hydrated. Overall, 219/644 decisions regarded the start of parenteral hydration, either 
alone or with other interventions. Italian health care professionals seem to perceive artificial hydration as more of a 
basic care need than artificial nutrition.36 However, it may well be possible that in many cases artificial hydration was 
implemented instead of tube feeding to minimize the family’s anguish, for what Hoffer calls “cosmetic reasons”.37 
However, the physicians stated they agreed with the decision. 
 Hospital admission occurred more frequently in HC and often resulted from an acute event, similar to the findings 
reported for NHs in a study by Lamberg et al.1 The NHs in our sample were more similar to “skilled NHs” and were 
equipped to care for severely disabled, frail patients, with doctors on site or on call. Consequently, patients in NHs may 
need hospitalization only for major medical treatments, such as surgery after a fall. Other treatments are offered on site, 
as they are in other comparable contexts where hospital admissions are also infrequent.38 The HC services considered in 
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this study were not equipped to deliver specialized or intensive treatments.27 In an older US study, HC patients were less 
often admitted to the hospital and less often exposed to feeding tubes and IV medications,39 but those patients were in 
better health (more independent and with a better cognitive performance score) compared with the patients in our study.  
     An almost total absence of ADs was found, confirming the findings of a previous research on NHs in Lombardy 
Region.18 This phenomenon is not, however, limited to Italy, as ADs are equally scarce in other European countries.40 
However, in Italy, ADs do not have legal force, and the few ADs that patients have created are simply an expression of 
wish rather than of will  
     In the NHs, CDs were more frequently aimed at reducing symptoms or suffering. Only in a minority of cases was the 
purpose to “ease death” or “avoid prolonging life”. In other countries, physicians may be more willing to alleviate pain 
or other symptoms, even if it means increasing the risk of hastening death.15 However, curative treatment with the 
purpose of prolonging survival was an important component of care, as evidenced by 20% of the CDs (134/644). This 
may be partly related to the frequent lack of legal representatives (guardians) and advanced directives.16,18 In these 
cases, the decision-making power of the NH physician is stronger than the influence of the GP on the family of a patient 
who is cared for at home; decisions for HC patients are more likely to be made jointly by the GP and the patient’s 
family. In the NHs, most CDs were only communicated with family members after they were made, despite the fact that 
the large majority of our NH patients received family visits every day or several times a day, and the medical staff was 
present for many hours of the day and during weekends. Thus, physicians would have had opportunities to share critical 
decisions before implementing them. In Lombardy, however, the 2012 Regional Licensing and Regulatory Directive 
requires treatment decisions, in case of cognitive incapacity, are made together with the court-appointed legal guardian 
(when available), and be communicated to the family; consequently, the type of doctor/family communication described 
in this paper may have changed, and the families may be more involved in the decision making or at least better 
informed about the decisions taken.  
     Several factors, such as the context (setting and culture41) and the vocational training of each professional, may 
affect the perception of the “criticality” of decision for older people with advanced dementia. Physicians may have 
different perceptions33 that can be explored only through discussions with those directly involved in the decision-
making process. 
Limits 
 When two or more CDs were reported during the same follow-up period for the same patient, our data might have 
resulted in a slight underestimation of decisions (e.g., pneumonia at the beginning of the period and a food intake 
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problem a week later that required a different decision). The lower number of CDs for artificial nutrition and hydration 
in HC might be explained by the higher hospitalization rate in HC. It is possible that hydration decisions were only 
made in the hospital.  
 We asked physicians about decision making rather than relying solely on data from charts. A major challenge, 
however, was the involvement of the GPs of the HC patients because they often did not visit the patients with the 
HC nurse, and they were not always available for interviews. Nevertheless, only 21 (13.4%) interviews were 
missing. Unfortunately, we did not have data about later decisions that were made in the hospital. 
 The aim of this study was to collect data regarding decisions that were perceived as critical and not to describe 
all of the decisions made for patients with advanced dementia. Although it is very unlikely given the decisions that 
were reported, it is possible that some decisions to hospitalize a patient, withhold a therapy or start parenteral 
hydration were not perceived as critical. 
Conclusions 
 Decisions that were critical to the survival or quality of life of patients with advanced dementia were made for 
approximately half of the patients within a 6-month time frame, and such decisions occurred more frequently in the 
NHs than in HC. Our study suggests that in clinical practice in Italy, advanced dementia is often not perceived or 
treated as a terminal illness, even by physicians whose main practice is in the NHs. Because decisions, treatments, and 
purposes are often focused on curing patients, Italian patients with advanced dementia may benefit from the 
implementation of palliative care principles. In particular, HC can implement measures to avoid hospitalization near the 
end of life. Such measures would also be of relevance in the care of individuals with advanced dementia in other 
countries with policies that aim to keep elderly patients in their homes for as long as possible.  
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Table 1: Population baseline characteristics  
 
Nursing home 
patients 
(n=315) 
Home care 
patients 
(n=181) 
p-value 
Demographics 
Male gender (%) 15.2         30.9 <0.0001 
Age, mean (SD)     84.5 (8.4)       87.0 (7.3) 0.0007 
Dementia 
Years since dementia diagnosis, median (IQR)    6.0 (4-9)* 6.0 (4-9) † 0.81 § 
Years since dementia diagnosis, mean (SD)   7.0 (4.6)*  6.76 (3.6) † 0.61 
FAST stage (%) 
FAST 7A,B 22.2  8.8 
<0.0001 
FAST 7C-F 77.8 91.2 
Discomfort 
DS-DAT median scores (IQR) 
9.0 (4-15) 6.0 (3-11) 0.0004§ 
Type of dementia (%) 
Alzheimer’s disease 
 
40.0 22.1 <0.0001 
Vascular dementia 
 
29.5 29.3 0.94 
Mixed dementia 
 
22.5 32.6 0.014 
Fronto-temporal dementia 
 
 0.6  0.6 0.91 
Lewy bodies dementia 
 
 0.3  1.7 0.11 
Main health problems (%) 
Musculoskeletal 64.4 26.0 <0.0001 
Ankylosis/contractures 59.4 39.2 <0.0001 
Heart disease 48.9 50.8 0.67 
Vascular disease, including stroke 36.5 30.4 0.16 
Urologic disease 27.3 23.8 0.38 
Metabolic disease 24.4 21.5 0.46 
Pressure sores 17.1 33.3 <0.0001 
 21 
Respiratory disease 15.9 12.7 0.33 
Psychiatric disease 14.6 8.3 0.04 
Cancer 9.2 5.5 0.14 
Skin problems 8.9 11.1 0.43 
Infections 1.6 1.1 0.66 
Treatments (%) 
IV hydration (any) or S.C.   14.6 15.4 0.79 
Tube feeding 8.6 9.9 0.61 
 
* n=306;  
† n=159;   
§=Mann-Whitney 
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Table 2. Problems that led to a CD in nursing homes and home care 
Problems and number of decisions Nursing home 
(CDs n=488) 
Home care 
(CDs n=156) 
 
p-value 
 N % N %  
Infections: respiratory tract  143 29.3 26 16.6 0.002 
Pneumonia (including aspiration pneumonia) 111 22.7 18 11.5  
Other respiratory tract infection 32 6.6 8 5.2 
Infections: other  89 18.2 42 26.9 0.02 
Other non-respiratory, non-urinary severe infection 61 12.5 35 22.4  
Urinary tract infection 28 6.4 7 4.6 
Nutritional problems 96 19.6 37 23.7 0.27 
Severe dysphagia  56 11.5 31 19.8  
Dehydration 22 4.5 4 2.5 
Food refusal 18 3.6 2 1.3 
Worsening of general conditions 84 17.2 37 23.7 0.07 
Worsening of a pre-existing disease  37 7.6 23 14.8  
General worsening/coma 18 3.6 2 1.3 
Restlessness 16 3.2 5 3.2 
Drowsiness 10 2.0 1 0.6 
Events that would require hospital admission 3 0.6 6 3.8 
Other conditions 76 15.5 14 8.9 0.04 
Anemia (≤7 Hb) 15 3.1 2 1.3  
Falls/trauma 15 3.1 2 1.3 
Vomiting/diarrhea 8 1.6 0 0 
Cancer 7 1.4 0 0 
Seizures  6 1.2 1 0.6 
Syncope/hypotension 5 1.0 2 1.3 
Other* 20 4.1 7 4.6 
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* Other: ≤5 decisions total: pain (5), stiffness (4), pressure sores (3), hypoglycemia (2). Other conditions that were 
reported only once: deep venous thrombosis, delirium, electrolyte imbalance, wasting, coagulation deficiency, 
drowsiness, hemorrhage, bleeding from PEG, relieving the family’s burden. 
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Table 3. CDs in nursing homes and in home care  
 Nursing home   
(CDs=488) 
Home care 
(CDs n=156) 
p-value 
 n          % n           %  
Antibiotics 130 26.6 40 25.7 0.81 
Artificial hydration (I.V. or S.C.) 106 21.7 18 11.5 0.005 
Antibiotics+hydration 88 18.0 7 4.5 <0.0001 
Diagnostic exams 30 6.2 8 5.1 0.64 
Symptom control (analgesics, sedatives for 
restlessness) 
30 6.2 7 4.4 0.44 
Drug administration (mostly steroids) 22 4.6 7 4.5 0.99 
Admission to hospital  15 3.1 39 25.5 <0.0001 
No intervention 18 3.7 18 11.5 0.0002 
Discontinuation of drugs 12 2.5 3 1.9 0.74 
Enteral nutrition 11 2.3 0 0 0.11 
Discontinuation of palliative sedation 8 1.6 2 1.3 0.81 
Deep or terminal sedation 7 1.41 1 0.7 0.49 
Discontinuation of other treatments* 5 0.8 1 0.7 0.74 
Discontinuation of artificial nutrition or hydration 4 0.8 0 0 0.63 
Blood transfusion 3 0.6 0 0 0.81 
Hydration and drugs 2 0.6 0 0 0.98 
Other (≤5 decisions)† 9 1.8 4 2.6 0.57 
 
* NH: drugs+sedation, sedation, hydration, nasogastric tube, antibiotics+hydration. 
HC: hydration+lab exams. 
†Fluid thickeners (5), use of restraints (2), physiotherapy (1), administration of food supplements (1), hydration + 
opioids (1), surgical cleaning of the wound (1), bladder catheter (1), oral feeding (1).  
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Table 4. Purposes of the CDs 
 NH (CDs=488) HC (CDs=156) 
Purpose  Total 
n         % 
1 purpose 
n 
>1 purpose 
n 
Total 
n         % 
1 purpose 
n 
>1 purpose 
n 
Reduce symptoms/suffering 396     81.1 268 128 89     57.0 72 17 
Prolong survival  134     27.5 45 89 36     23.1 23 13 
Avoid/stop futile treatments   39      8.0 15 24 16     10.3 9 7 
Avoid prolonging survival   25      5.1 7 18   1      0.6 0 1 
Ease death*    8       1.6 0 8    0      0 0 0 
Other  18       3.7 10 8   2      1.2 2 0 
 
The purpose was missing for 11 CDs in NHs and 29 in HC.   
No doctor’s interview took place for 21 CDs: in 8 cases because of organizational problems and in 13 cases because the 
doctor was unavailable. 
* i.e. improving the Quality of Death by minimizing suffering as death approaches, following the Palliative Care 
philosophy 
 
 
